Global demand for health equity has created an acute need for accessible diagnostic testing. Over the course of this series, the evidence and interviews with key opinion leaders that we've explored show a vast range of available products and technologies. In a saturated industry, developers of diagnostic products must reach beyond the confines of central lab facilities and enable decentralised solutions capable of delivering lab-quality results — all while minimising "time to results" and maintaining ease of interpretation. It is these solutions which will bring real gains in terms of patient benefit, healthcare efficiencies, and wider societal returns.
We are confident that, more than ever before, it is true to say that distributing diagnostics will help shape the future of healthcare.
